Cargando…

How Do Seniors Respond to 100% Cost-Sharing for Prescription Drugs? Quality of the Evidence Underlying Opinions About the Medicare Part D Coverage Gap

Popular press coverage of the Medicare Part D coverage gap is based largely on research conducted using retrospective analyses of administrative claims data. These datasets are incomplete because they lack information about methods of obtaining medication that are commonly used by seniors, including...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fairman, Kathleen A., Curtiss, Frederic R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2011
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437847/ https://www.ncbi.nlm.nih.gov/pubmed/21657807 http://dx.doi.org/10.18553/jmcp.2011.17.5.382

Ejemplares similares

The Elephant in the Pharmacy: Patient Choice Is the Big Challenge That No One Talks About in Affordability of Prescription Drugs
por: Fairman, Kathleen A., et al.
Publicado: (2007)

VBID, the PPACA, and FREEE Medications: Did Politics Trump the Evidence About Cost Sharing?
por: Fairman, Kathleen A., et al.
Publicado: (2012)

The Editors Respond Regarding the Shortcomings in Reported Research on Value-Based Insurance Design
por: Fairman, Kathleen A., et al.
Publicado: (2008)

Medicare Part D Coverage Gap Discount Program Beginning in 2011
por: Cahill, Judith A.
Publicado: (2010)

Changes in Drug Utilization during a Gap in Insurance Coverage: An Examination of the Medicare Part D Coverage Gap
por: Polinski, Jennifer M., et al.
Publicado: (2011)

Regulatory Actions on the Off-Label Use of Prescription Drugs: Ongoing Controversy and Contradiction in 2009 and 2010
por: Fairman, Kathleen A., et al.
Publicado: (2010)

Correction: Changes in Drug Utilization during a Gap in Insurance Coverage: An Examination of the Medicare Part D Coverage Gap
Publicado: (2014)

Entering and Exiting the Medicare Part D Coverage Gap: Role of Comorbidities and Demographics
por: Ettner, Susan L., et al.
Publicado: (2010)

Prescription Drug Coverage and Spending for Medicare Beneficiaries
por: Poisal, John A., et al.
Publicado: (1999)

Prescription Drug Expenditures, Financial Burden, and Health Plan Satisfaction Among Medicare Beneficiaries
por: Curtiss, Frederic R.
Publicado: (2003)

ADD or ADHD or What Exactly?--GIGO Part II and Other Lessons in Research with Administrative Claims
por: Curtiss, Frederic R., et al.
Publicado: (2007)

Effects of Medicare Part D coverage gap closure on utilization of branded and generic drugs
por: Liu, Judith, et al.
Publicado: (2022)

The Future of Prescription Drug Cost-Sharing: Real Progress or Dropped Opportunity?
por: Fairman, Kathleen A.
Publicado: (2008)

Evolution of Medicaid Coverage of Medicare Cost Sharing
por: Carpenter, Letty
Publicado: (1998)

Coverage of New Drugs in Medicare Part D
por: NACI, HUSEYIN, et al.
Publicado: (2022)

MCBS Highlights: Prescription Drug Coverage Among Medicare Beneficiaries
por: Regan, Joseph F., et al.
Publicado: (2007)

The impact of Medicare prescription drug coverage on the use of antidementia drugs
por: Fowler, Nicole R, et al.
Publicado: (2013)

What Should Be Done About Bias and Misconduct in Clinical Trials?
por: Fairman, Kathleen A., et al.
Publicado: (2009)

Health Costs and Outcomes Associated with Medicare Part D Prescription Drug Cost-Sharing in Beneficiaries on Dialysis
por: Park, Haesuk, et al.
Publicado: (2015)

Tough Questions About the Value of Statin Therapy for Primary Prevention: Did JUPITER Miss the Moon?
por: Curtiss, Frederic R., et al.
Publicado: (2010)

What Do We Really Know About VBID? Quality of the Evidence and Ethical Considerations for Health Plan Sponsors
por: Fairman, Kathleen A., et al.
Publicado: (2011)

Call for Letters Regarding Disclosure of Potential Conflicts of Interest in the Managed Care Literature -- Too Much, Too Little, or Just About Right?
por: Fairman, Kathleen A., et al.
Publicado: (2009)

Medicare Second Surgical Opinion Programs: The Effect of Waiving Cost-Sharing
por: Friedlob, Alan S.
Publicado: (1982)

Switching Antidepressant Drug Therapy Helps Some Patients Some of the Time--What TORDIA, STAR*D, and Observational Research Have Taught Us About Treatment-Resistant Depression
por: Curtiss, Frederic R., et al.
Publicado: (2008)

Medicare PPOs and Managed Care
por: Curtiss, Frederic R.
Publicado: (2003)

The impact of weight loss among seniors on Medicare spending
por: Thorpe, Kenneth E, et al.
Publicado: (2013)

Correlation of antimicrobial prescription rate and county income in medicare part D
por: Volpi, Connor, et al.
Publicado: (2019)

Factors Associated With Prescriptions for Branded Medications in the Medicare Part D Program
por: Socal, Mariana P., et al.
Publicado: (2021)

Denials, Surprise Charges, Starting Over: How Medicare Recipients Navigate the Medicare Mental Health Coverage Gap
por: Fullen, Matthew, et al.
Publicado: (2020)

Coverage of Novel Therapeutic Agents by Medicare Prescription Drug Plans Following FDA Approval
por: Shaw, Daniel L., et al.
Publicado: (2018)

Still Looking for Health Outcomes in All the Wrong Places? Misinterpreted Observational Evidence, Medication Adherence Promotion, and Value-Based Insurance Design
por: Fairman, Kathleen A., et al.
Publicado: (2009)

Protecting Patients from Adverse Drug Events: Propoxyphene, PIMs, and Drugs to Avoid in Older Adults
por: Curtiss, Frederic R., et al.
Publicado: (2011)

Clinical Quality Indicators and Provider Financial Incentives: Does Money Matter?
por: Fairman, Kathleen A., et al.
Publicado: (2010)

Utilization Management Opportunities for Palivizumab for Prophylaxis of Respiratory Syncytial Virus Complications in Infants
por: Curtiss, Frederic R., et al.
Publicado: (2010)

Does Medicalization of Life Imperil Health? Expanding Indications for Diagnosis and Treatment of Chronic “Disease”
por: Fairman, Kathleen A., et al.
Publicado: (2011)

Managed Care and Health Care Reform: Everything Old Is New Again
por: Fairman, Kathleen A., et al.
Publicado: (2009)

Diabetes Drug Therapy -- First Do No Harm
por: Curtiss, Frederic R., et al.
Publicado: (2008)

Rethinking the Whodunnit Approach to Assessing the Quality of Health Care Research -- A Call to Focus on the Evidence in Evidence-Based Practice
por: Fairman, Kathleen A., et al.
Publicado: (2008)

Making the World Safe for Evidence-Based Policy: Let's Slay the Biases in Research on Value-Based Insurance Design
por: Fairman, Kathleen A., et al.
Publicado: (2008)

It Depends on What Mean Means: Averaging Versus Event Patterning in Analyses of Administrative Claims Data
por: Fairman, Kathleen A., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_7nbteo49m3uef71tknv8kouhpb